Financials

  • Market Capitalization 106.83 M
  • Employee 152
  • Founded 2013
  • CEO N/A
  • Website www.lenz-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XDH4NZ2
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.61
ratio cours/chiffre d'affaires
24.15

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3816
ENGN
enGene Therapeutics Inc. - Common Stock
1.63 USD-4.12%-9.44%-12.83%-80.60%109.24 M USD
3822
CBUS
Cibus, Inc. - Class A Common Stock
1.41 USD-4.73%-9.62%-4.08%-19.89%107.76 M USD
3830
VANI
Vivani Medical, Inc. - Common Stock
1.18 USD-0.84%-5.60%-6.35%-10.61%106.44 M USD
3835
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
6.13 USD-7.68%-20.39%-47.70%-59.16%105.14 M USD